Tonic-Clonic Seizures Market

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic?clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
Tonic-Clonic Seizures Market contains market size and forecasts of Tonic-Clonic Seizures in Global, including the following market information:
Global Tonic-Clonic Seizures Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tonic-Clonic Seizures market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Barbiturates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tonic-Clonic Seizures include Pfizer, Johnson & Johnson, UCB Celltech, Abbott Laboratories, GlaxoSmithKline, Novartis, Sanofi, Takeda and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tonic-Clonic Seizures companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tonic-Clonic Seizures Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tonic-Clonic Seizures Market Segment Percentages, by Type, 2021 (%)
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Global Tonic-Clonic Seizures Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tonic-Clonic Seizures Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Academic and Research Centers
Others
Global Tonic-Clonic Seizures Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tonic-Clonic Seizures Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tonic-Clonic Seizures revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tonic-Clonic Seizures revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical